Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Zynerba Pharma CS (ZYNE)

19.00 +0.09 (+0.48%)

5/26/2017  4:00pm

Open:

18.94

Pre. Close:

18.91

High:

19.10

Low:

18.58

Volume:

188,972

Market Cap:

251.73M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

19.58 - 19.61

19.61 - 19.86

Low:

17.65 - 17.72

17.72 - 18.26

Close:

18.25 - 18.4

18.4 - 19.6

Technical analysis  (as of: 2017-05-26 4:43:00 PM)

Overall:

      

Stoxline posted a STRONG BUY today, same as yesterday. This stock still seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 25.09     One year: 27.85

Support:

Support1: 17.66    Support2: 14.69

Resistance:

Resistance1: 21.48    Resistance2: 23.84

Pivot:

18.80

Moving Averages:

MA(5): 18.47     MA(20): 19.25

MA(100): 20.30     MA(250): 14.73

MACD:

MACD(12,26): -0.75     Signal(12,26,9): -0.78

%K %D:

%K(14,3): 35.68     %D(3): 23.69

RSI:

RSI(14): 44.90

52-Week:

High: 25.95  Low: 6.31  Change(%): 117.4

Average Vol(K):

3-Month: 394  10-Days 326

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ZYNE has closed below upper band by 41.3%. Bollinger Bands are 55.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to ZYNE's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 19 Jan 2017 16:48:29 GMT
Why Zynerba Pharmaceuticals Inc. Is Tanking Today

Mon, 29 May 2017 01:18:45 GMT
Zynerba Pharmaceuticals Inc (ZYNE) Chairman Purchases $98500.00 in Stock

Tue, 09 May 2017 11:26:15 GMT
Zynerba Pharmaceuticals Reports First Quarter 2017 Financial Results and ...

Thu, 06 Apr 2017 17:03:45 GMT
Best Stocks for 2017: Zynerba Pharmaceuticals Inc (ZYNE) Stock Dominates in Q1

Fri, 24 Mar 2017 13:30:00 GMT
Stock Volatility Risk Alert: Zynerba Pharmaceuticals Inc Realized Volatility ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

Shares Float (M)

11.23

% Held by Insiders

% Held by Institutions

Shares Short (K)

1610

Shares Short Prior Month (K)

1880

Stock Financials

EPS

-2.580

EPS Est. Current Year

-2.430

EPS Est. Next Year

-2.730

EPS Est. Next Quarter

-0.600

Forward EPS

Book Value (p.s.)

2.960

PEG Ratio

Profit Margin

Operating Margin

-320105.22

Return on Assets (ttm)

-36.2

Return on Equity (ttm)

-67.5

Qtrly Rev. Growth

-100.0

Gross Profit (p.s.)

0.001

Sales Per Share

0.001

EBITDA (p.s.)

-1.751

Qtrly Earnings Growth

Operating Cash Flow (M)

-20.44

Levered Free Cash Flow (M)

-11.78

FoxReading.com

Valuation

P/E

-7.36

P/E Growth Ratio

P/BV

6.42

P/S

34619.31

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.